Exploring the Inhibitory Potential of Novel Bioactive Compounds from Mangrove Actinomycetes Against Nsp10 the Major Activator of SARS-CoV-2 Replication

Overview

Journal Chem Zvesti

Publisher De Gruyter

Specialty Chemistry

Date 2022 Feb 1

PMID 35103034

Authors

Shabbir Muhammad

Mahnoor Qaisar

Javed Iqbal

Rasheed Ahmad Khera

Abdullah G Al-Sehemi

Saleh S Alarfaji

Muhammad Adnan

Affiliations

Soon will be listed here.

Abstract

Graphical Abstract:

Supplementary Information: The online version contains supplementary material available at 10.1007/s11696-021-01997-x.

Citing Articles

Exploring cyclin-dependent kinase inhibitors: a comprehensive study in search of CDK-6 inhibitors using a pharmacophore modelling and dynamics approach.

Chagaleti B, Saravanan V, Vellapandian C, Kathiravan M RSC Adv. 2023; 13(48):33770-33785.

PMID: 38019988 PMC: 10655667. DOI: 10.1039/d3ra05672d.

Repurposing and computational design of PARP inhibitors as SARS-CoV-2 inhibitors.

Rampogu S, Jung T, Ha M, Lee K Sci Rep. 2023; 13(1):10583.

PMID: 37386052 PMC: 10310815. DOI: 10.1038/s41598-023-36342-7.

Actinomycetes as Producers of Biologically Active Terpenoids: Current Trends and Patents.

Tarasova E, Luchnikova N, Grishko V, Ivshina I Pharmaceuticals (Basel). 2023; 16(6).

PMID: 37375819 PMC: 10301674. DOI: 10.3390/ph16060872.

Exploring the inhibitory potential of novel piperidine-derivatives against main protease (M) of SARS-CoV-2: A hybrid approach consisting of molecular docking, MD simulations and MMPBSA analysis.

Rafique A, Muhammad S, Iqbal J, Al-Sehemi A, Alshahrani M, Ayub K J Mol Liq. 2023; 382:121904.

PMID: 37151376 PMC: 10131809. DOI: 10.1016/j.molliq.2023.121904.

Characterization of Bioactive Actinomycetes Isolated from Kadolkele Mangrove Sediments, Sri Lanka.

Naligama K, Weerasinghe K, Halmillawewa A Pol J Microbiol. 2022; 71(2):191-204.

PMID: 35676828 PMC: 9252147. DOI: 10.33073/pjm-2022-017.

References

Fatima S, Gupta P, Sharma S, Sharma A, Agarwal S . ADMET profiling of geographically diverse phytochemical using chemoinformatic tools. Future Med Chem. 2019; 12(1):69-87. DOI: 10.4155/fmc-2019-0206. View

Kim S, Chen J, Cheng T, Gindulyte A, He J, He S . PubChem in 2021: new data content and improved web interfaces. Nucleic Acids Res. 2020; 49(D1):D1388-D1395. PMC: 7778930. DOI: 10.1093/nar/gkaa971. View

Bouvet M, Lugari A, Posthuma C, Zevenhoven J, Bernard S, Betzi S . Coronavirus Nsp10, a critical co-factor for activation of multiple replicative enzymes. J Biol Chem. 2014; 289(37):25783-96. PMC: 4162180. DOI: 10.1074/jbc.M114.577353. View

Pires D, Blundell T, Ascher D . pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures. J Med Chem. 2015; 58(9):4066-72. PMC: 4434528. DOI: 10.1021/acs.jmedchem.5b00104. View

Morris G, Huey R, Lindstrom W, Sanner M, Belew R, Goodsell D . AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J Comput Chem. 2009; 30(16):2785-91. PMC: 2760638. DOI: 10.1002/jcc.21256. View

Zia M, Muhammad S, Shafiq-urRehman , Bibi S, Abbasi S, Al-Sehemi A . Exploring the potential of novel phenolic compounds as potential therapeutic candidates against SARS-CoV-2, using quantum chemistry, molecular docking and dynamic studies. Bioorg Med Chem Lett. 2021; 43:128079. PMC: 8087859. DOI: 10.1016/j.bmcl.2021.128079. View

Meng Z, Yu H, Li L, Tao W, Chen H, Wan M . Total synthesis and antiviral activity of indolosesquiterpenoids from the xiamycin and oridamycin families. Nat Commun. 2015; 6:6096. PMC: 4347019. DOI: 10.1038/ncomms7096. View

Bagaria A, Jaravine V, Huang Y, Montelione G, Guntert P . Protein structure validation by generalized linear model root-mean-square deviation prediction. Protein Sci. 2011; 21(2):229-38. PMC: 3324767. DOI: 10.1002/pro.2007. View

Trott O, Olson A . AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2009; 31(2):455-61. PMC: 3041641. DOI: 10.1002/jcc.21334. View

10.

Muhammad S, Hassan S, Al-Sehemi A, Shakir H, Khan M, Irfan M . Exploring the new potential antiviral constituents of Moringa oliefera for SARS-COV-2 pathogenesis: An molecular docking and dynamic studies. Chem Phys Lett. 2021; 767:138379. PMC: 7835070. DOI: 10.1016/j.cplett.2021.138379. View

11.

Marshall G . Computer-aided drug design. Annu Rev Pharmacol Toxicol. 1987; 27:193-213. DOI: 10.1146/annurev.pa.27.040187.001205. View

12.

Khan R, Jha R, Amera G, Jain M, Singh E, Pathak A . Targeting SARS-CoV-2: a systematic drug repurposing approach to identify promising inhibitors against 3C-like proteinase and 2'-O-ribose methyltransferase. J Biomol Struct Dyn. 2020; 39(8):2679-2692. PMC: 7189412. DOI: 10.1080/07391102.2020.1753577. View

13.

Ding L, Munch J, Goerls H, Maier A, Fiebig H, Lin W . Xiamycin, a pentacyclic indolosesquiterpene with selective anti-HIV activity from a bacterial mangrove endophyte. Bioorg Med Chem Lett. 2010; 20(22):6685-7. DOI: 10.1016/j.bmcl.2010.09.010. View

14.

Ma Y, Wu L, Shaw N, Gao Y, Wang J, Sun Y . Structural basis and functional analysis of the SARS coronavirus nsp14-nsp10 complex. Proc Natl Acad Sci U S A. 2015; 112(30):9436-41. PMC: 4522806. DOI: 10.1073/pnas.1508686112. View

15.

Rzesikowska K, Krawczuk A, Kalinowska-Tluscik J . Electrostatic potential and non-covalent interactions analysis for the design of selective 5-HT ligands. J Mol Graph Model. 2019; 91:130-139. DOI: 10.1016/j.jmgm.2019.06.007. View

16.

Encinar J, Menendez J . Potential Drugs Targeting Early Innate Immune Evasion of SARS-Coronavirus 2 via 2'-O-Methylation of Viral RNA. Viruses. 2020; 12(5). PMC: 7291090. DOI: 10.3390/v12050525. View

17.

Humphrey W, Dalke A, Schulten K . VMD: visual molecular dynamics. J Mol Graph. 1996; 14(1):33-8, 27-8. DOI: 10.1016/0263-7855(96)00018-5. View

18.

Carugo O, Pongor S . A normalized root-mean-square distance for comparing protein three-dimensional structures. Protein Sci. 2001; 10(7):1470-3. PMC: 2374114. DOI: 10.1110/ps.690101. View

19.

Christina A, Christapher V, Bhore S . Endophytic bacteria as a source of novel antibiotics: An overview. Pharmacogn Rev. 2013; 7(13):11-6. PMC: 3731874. DOI: 10.4103/0973-7847.112833. View

20.

Menachery V, Yount Jr B, Josset L, Gralinski L, Scobey T, Agnihothram S . Attenuation and restoration of severe acute respiratory syndrome coronavirus mutant lacking 2'-o-methyltransferase activity. J Virol. 2014; 88(8):4251-64. PMC: 3993736. DOI: 10.1128/JVI.03571-13. View